All stock reports

NEWGEN evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-09-23T23:41:39.391599+00:00

Metrics

latest_annual_period
2026-03-31
revenue
15743956000.0
net_income
3005764000.0
operating_cash_flow
2630629000.0
free_cash_flow
2533114000.0
total_assets
24424750000.0
total_liabilities
6651255000.0
total_equity
17773495000.0
cash
4115206000.0
total_debt
393560999.0
revenue_growth
0.05885911915372821
earnings_growth
-0.0465229296566706
net_margin
0.19091542176566043
roe
0.16911496585224234
debt_to_equity
0.022143140614718716
cash_conversion
0.8751947924055249
free_cash_flow_margin
0.16089437749953062
trailing_pe
24.9077
forward_pe
0.0
peg_ratio
Not supplied
price_to_book
4.4516
dividend_yield
0.0

Other positional research

Research only

1 opportunity assessments; compare evidence and conditions below.

Price Dislocation

Research only. Direction: LONG.

Flags large price dislocations for research without asserting unsupported fundamental quality

  • No active, unexpired validation authority for this exact strategy and horizon.
  • A source-backed entry, invalidation, exit and cost plan is not supplied.
Eligible expression
None selected
Expression comparison
No eligible instrument selected.
Invalidation
Continued price deterioration or adverse fundamental evidence
Entry rule
Not supplied
Entry range (INR)
Not supplied
Exit / review rule
Not supplied
Planned exit
Not supplied
Plan valid until
Not supplied
Promotion reference
Not supplied
Instrument scenarios in INR; quantities are illustrative, not personal sizing
InstrumentEvidence statusContractQuantityCapital / marginTarget P&L after costsStop-level scenario P&LStress lossConditions and limitations
NO_POSITIONAvailableNot suppliedNot suppliedNot supplied0.000.00Not suppliedNo new position; incremental trading P&L is zero.
CASHUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
FUTURESUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
OPTIONSUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
  • No reader capital or loss budget supplied
Decision provenance and limitations
Decision ID
decision-8cf556dd2005035ca84ab0c4c9245d885b8b5ed2f23cf93a59b31e070b1a729e
Policy
stock-decisions-v1
Evidence bundle hash
0ad174264cf7e018af9e58a4978dd2d3d5297c068125fcc758733bf1efff184c
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: 47817f25707dab456a0504a7ef43c66223c9952179a22af2c3d70fb03daa293f
  • daily-price: 98627d53900dc2226ecb20940ee59362f59fd90ef9d4fb2e3ffcdea5dcf2014a
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Evidence briefing

The local language model selected and grouped the following supplied facts.

Overview

Price source verification: REPAIRED. The cached closing price on 2026-10-01 was INR 456.35. The trailing 5-session price return was -7.55%. The trailing 20-session price return was -12.12%. The trailing 60-session price return was -0.90%. The trailing 250-session price return was -49.26%.

Risks

The closing price was -53.69% below its highest close in the available trailing year. Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.

Follow Up

The cached financial metric latest annual period is 2026-03-31. The cached financial metric revenue growth is 0.05885911915372821. The cached financial metric net margin is 0.19091542176566043. The cached financial metric roe is 0.16911496585224234. The cached financial metric debt to equity is 0.022143140614718716. The cached financial metric cash conversion is 0.8751947924055249.

Cached observations and evidence limits